GO:0002407 dendritic cell chemotaxis: Migration Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002407 dendritic cell chemotaxis is defined as the movement of a dendritic cell in response to an external stimulus.
• Dendritic cell chemotaxis is essential for trafficking from peripheral tissues to lymph nodes, where dendritic cells present antigen to T cells.
• The process is regulated by chemokine gradients, including CCL19 and CCL21, and by chemokine receptors such as CCR5 and CCR7.
• TRPM2-mediated lysosomal Ca2+ release is required for dendritic cell maturation and chemotaxis.
• Dendritic cell chemotaxis can be studied using micro-fabricated devices, live-cell microscopy, and genetic knockout models.
• Dysregulated dendritic cell chemotaxis contributes to autoimmune diseases such as rheumatoid arthritis and to impaired immune responses in HIV infection.
Description
Dendritic cells are specialized antigen-presenting cells that bridge innate and adaptive immunity. Their ability to migrate directionally toward chemical cues, a process known as chemotaxis, is fundamental for initiating immune responses. GO:0002407 dendritic cell chemotaxis describes the movement of a dendritic cell in response to an external stimulus. This biological process ensures that dendritic cells can leave peripheral tissues, enter lymphatic vessels, and reach lymph nodes to present antigens to T cells. Understanding dendritic cell chemotaxis is critical for immunology research, vaccine development, and therapies targeting autoimmune and infectious diseases. Experimental models, including micro-fabrication-based migration assays and live-cell microscopy, have been developed to quantify this process. Moreover, genetic and pharmacological studies have identified key molecular regulators, such as TRPM2 and CCR5, that control dendritic cell chemotaxis.
dendritic cell chemotaxis At A Glance
| GO ID | GO:0002407 |
|---|---|
| GO term | dendritic cell chemotaxis |
| Ontology | biological_process |
| Synonym | none |
| Major function | Directed movement of dendritic cells in response to external chemical stimuli |
| Definition | The movement of a dendritic cell in response to an external stimulus. |
| Related process | Dendritic cell migration to lymph nodes via lymphatic vessels |
| Key regulators | CCR5, CCR7, TRPM2, CCL19, CCL21 |
What Is GO:0002407?
GO:0002407 dendritic cell chemotaxis is the directed movement of a dendritic cell along a chemical gradient in response to an external stimulus. This process is a type of cell chemotaxis and is distinct from random migration. It involves sensing chemokines, reorganizing the cytoskeleton, and physically translocating the cell toward the source of the stimulus.
Why Is dendritic cell chemotaxis Important in Cell Biology?
Dendritic cell chemotaxis is a cornerstone of immune surveillance and response. Without proper chemotaxis, dendritic cells cannot reach lymph nodes to activate T cells, leading to impaired immunity. This process is also implicated in autoimmune diseases, where aberrant dendritic cell migration can exacerbate inflammation, as seen in collagen-induced arthritis models. Furthermore, pathogens such as HIV-1 can modulate dendritic cell chemotaxis to evade immune detection. Therefore, understanding the molecular mechanisms of dendritic cell chemotaxis is essential for developing targeted immunotherapies and vaccines.
• Enables dendritic cells to transport antigens from peripheral tissues to lymph nodes.
• Required for T cell activation and adaptive immune responses.
• Dysregulated in autoimmune diseases such as rheumatoid arthritis.
• Modulated by pathogens, including HIV-1, to impair immune activation.
• Involves calcium signaling through TRPM2 channels.
• Can be studied using micro-fabricated chemotaxis devices for precise quantification.
• Chemokine receptors such as CCR5 and CCR7 are key therapeutic targets.
• Dendritic cell-derived chemokines like CCL5 can recruit other immune cells.
• Follicular dendritic cells influence B cell chemotaxis, linking to humoral immunity.
• Live-cell microscopy reveals distinct chemokinetic and chemotactic responses in immune cells.
What Happens During dendritic cell chemotaxis?
Chemokine Sensing and Receptor Activation
In simple terms: Dendritic cells detect chemical signals from other cells or tissues.
Dendritic cells express chemokine receptors on their surface that bind specific chemokines. For example, CCR5 binds chemokines such as CCL5, and CCR7 binds CCL19 and CCL21. Upon ligand binding, these G protein-coupled receptors activate intracellular signaling cascades that initiate cell polarization and movement. In the context of HIV-1, complement-opsonized virus can impair NK cell chemotaxis toward dendritic cells, highlighting the importance of receptor-mediated sensing.
Calcium Signaling and Lysosomal Release
In simple terms: Calcium ions inside the cell act as signals to trigger movement.
TRPM2, a calcium-permeable channel, mediates lysosomal Ca2+ release, which is required for dendritic cell maturation and chemotaxis. This calcium signal modulates cytoskeletal dynamics and integrin activation necessary for directed migration. Inhibition or knockout of TRPM2 impairs the ability of dendritic cells to migrate toward chemokines.
Cytoskeletal Rearrangement and Cell Polarization
In simple terms: The cell changes its shape to move forward.
Activation of chemokine receptors leads to actin polymerization at the leading edge and myosin contraction at the rear, driving cell polarization and forward movement. This process is tightly regulated by Rho GTPases and other signaling molecules. Micro-fabrication studies have visualized these morphological changes in real time.
Directed Migration Along Chemokine Gradients
In simple terms: The cell crawls toward higher concentrations of the chemical signal.
Dendritic cells migrate along gradients of chemokines such as CCL19 and CCL21, which are produced in lymph nodes. This directed movement is essential for dendritic cells to enter lymphatic vessels and reach lymph nodes. Live-cell microscopy has shown that human T cells primarily respond chemokinetically within a CCL19 gradient, whereas dendritic cells undergo true chemotaxis.
Interaction with Other Immune Cells
In simple terms: Dendritic cells communicate with other immune cells during migration.
Dendritic cells can secrete chemokines such as CCL5 to recruit T cells, as shown in IL-32γ-induced chemotaxis. Follicular dendritic cells also promote B cell chemotaxis, indicating a broader role in organizing immune cell positioning. These interactions are critical for mounting effective immune responses.
Key Genes Involved in GO:0002407 dendritic cell chemotaxis
The following genes and proteins are experimentally validated regulators or markers of dendritic cell chemotaxis.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CCR5 | Chemokine receptor mediating dendritic cell chemotaxis | Target for anti-arthritic drugs; knockout reduces chemotaxis |
| CCR7 | Receptor for CCL19/CCL21; guides dendritic cells to lymph nodes | Essential for lymph node homing; studied in migration assays |
| TRPM2 | Calcium channel mediating lysosomal Ca2+ release | Required for dendritic cell maturation and chemotaxis |
| CCL19 | Chemokine ligand for CCR7 | Induces chemotaxis in dendritic cells; used in gradient assays |
| CCL21 | Chemokine ligand for CCR7 | Expressed in lymph nodes; promotes dendritic cell migration |
| CCL5 | Chemokine secreted by dendritic cells | Recruits T cells; induced by IL-32γ |
| IL32 | Cytokine that induces CCL5 production | Modulates dendritic cell-mediated T cell chemotaxis |
| CD209 | C-type lectin receptor on dendritic cells | Involved in pathogen recognition and migration |
| ITGAM | Integrin alpha-M; mediates adhesion during migration | Required for dendritic cell trafficking |
| RHOA | Rho GTPase; regulates actin cytoskeleton | Controls cell polarization during chemotaxis |
| RAC1 | Rho GTPase; regulates lamellipodia formation | Essential for directed migration |
| CDC42 | Rho GTPase; regulates filopodia and polarity | Implicated in chemotaxis signaling |
| PIK3CD | Phosphoinositide 3-kinase catalytic subunit delta | Mediates chemokine receptor signaling |
| AKT1 | Serine/threonine kinase; downstream of PI3K | Promotes cell survival and migration |
| MAPK1 | Mitogen-activated protein kinase 1 | Transduces chemokine signals to cytoskeleton |
| NFKB1 | Transcription factor; regulates inflammatory genes | Modulates chemokine expression in dendritic cells |
| STAT3 | Signal transducer and activator of transcription 3 | Regulates dendritic cell maturation and migration |
How Is dendritic cell chemotaxis Regulated?
Dendritic cell chemotaxis is regulated at multiple levels. Chemokine receptor expression is modulated during dendritic cell maturation, with CCR7 upregulated upon activation to promote lymph node homing. Intracellular calcium signaling through TRPM2 is required for chemotaxis, and its inhibition impairs migration. Additionally, inflammatory cytokines such as IL-32γ can induce dendritic cells to secrete CCL5, which in turn recruits T cells. Pharmacological agents, such as the artesunate-isatin hybrid CT3-1, can suppress dendritic cell chemotaxis by abrogating CCR5 signaling, as shown in collagen-induced arthritis models. These regulatory mechanisms ensure that dendritic cell migration is tightly controlled in space and time.
dendritic cell chemotaxis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CCR5 | Rheumatoid arthritis | Collagen-induced arthritis in mice; CCR5 knockout dendritic cells |
| TRPM2 | Immune dysfunction | TRPM2 knockout mice; dendritic cell chemotaxis assays |
| CCR7 | Lymph node metastasis | CCR7 knockout mice; adoptive transfer models |
| IL32 | Inflammatory diseases | IL-32γ transgenic mice; T cell chemotaxis assays |
| CD209 | HIV infection | Human dendritic cells exposed to complement-opsonized HIV-1 |
Rheumatoid Arthritis
Dendritic cell chemotaxis contributes to the pathogenesis of rheumatoid arthritis by promoting the recruitment of dendritic cells to inflamed joints. In a collagen-induced arthritis model, the novel compound CT3-1 suppressed arthritis by abrogating CCR5-mediated dendritic cell chemotaxis. This suggests that targeting dendritic cell chemotaxis could be a therapeutic strategy for autoimmune arthritis.
HIV Infection
HIV-1 can impair immune responses by modulating dendritic cell chemotaxis. Complement-opsonized HIV-1 exposed to dendritic cells leads to impaired NK cell activation and chemotaxis toward dendritic cells. This immune evasion mechanism may contribute to viral persistence and pathogenesis.
Cancer and Lymphatic Metastasis
Dendritic cell trafficking through lymphatic vessels is essential for immune surveillance, and its dysregulation may affect anti-tumor immunity. Understanding how dendritic cells migrate to lymph nodes could inform cancer immunotherapy approaches.
From dendritic cell chemotaxis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CCR5 mediate dendritic cell chemotaxis in arthritis? | CCR5 knockout mice or CRISPR knockout dendritic cells |
| Is TRPM2 required for dendritic cell chemotaxis? | TRPM2 knockout mice or siRNA knockdown |
| How do dendritic cells migrate in a CCL19 gradient? | Micro-fabricated chemotaxis device with live-cell microscopy |
| Can a point mutation in CCR7 affect ligand binding? | CRISPR knock-in of mutant CCR7 in dendritic cells |
| Does overexpression of CCL5 enhance T cell recruitment? | Lentiviral overexpression of CCL5 in dendritic cells |
| What is the role of follicular dendritic cells in B cell chemotaxis? | In vitro co-culture of follicular dendritic cells and B cells |
How to Study the dendritic cell chemotaxis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell microscopy | Real-time cell movement and morphology | Visualizing chemotaxis in CCL19 gradients |
| Micro-fabricated device | Directed migration under controlled gradients | Quantifying dendritic cell chemotaxis |
| Transwell assay | Number of migrated cells | Screening chemokine receptor inhibitors |
| CRISPR knockout | Gene requirement for chemotaxis | Validating CCR5 or TRPM2 function |
| Flow cytometry | Cell surface marker expression | Assessing dendritic cell maturation |
| Calcium imaging | Intracellular Ca2+ flux | Measuring TRPM2-mediated lysosomal release |
| ELISA | Chemokine secretion (e.g., CCL5) | Quantifying IL-32γ-induced CCL5 |
| Co-culture assays | Cell-cell interactions | Studying follicular dendritic cell-B cell chemotaxis |
Live-Cell Microscopy
Live-cell microscopy allows real-time visualization of dendritic cell migration in response to chemokine gradients. This method has been used to show that human T cells primarily respond chemokinetically within a CCL19 gradient, whereas dendritic cells undergo true chemotaxis. It provides quantitative data on cell speed, directionality, and morphology.
Micro-Fabricated Chemotaxis Devices
Micro-fabrication techniques create stable chemical gradients for studying dendritic cell migration. Vargas et al. developed a micro-fabricated device to study dendritic cell migration, enabling precise control of gradient shape and concentration. This approach is ideal for high-resolution analysis of chemotactic responses.
Genetic Knockout and Knockdown
CRISPR/Cas9-mediated knockout or siRNA knockdown of candidate genes, such as CCR5 or TRPM2, can determine their requirement for dendritic cell chemotaxis. For example, TRPM2 knockout impairs dendritic cell maturation and chemotaxis, and CCR5 inhibition suppresses chemotaxis in arthritis models.
Flow Cytometry and Transwell Assays
Transwell migration assays combined with flow cytometry quantify the number of dendritic cells that migrate toward a chemokine source. This method has been used to assess NK cell chemotaxis toward dendritic cells exposed to HIV-1 and to measure T cell chemotaxis induced by dendritic cell-derived CCL5.
How CRISPR Can Be Used to Study GO:0002407 dendritic cell chemotaxis
Knockout
CRISPR/Cas9 knockout of genes such as CCR5 or TRPM2 in dendritic cells can definitively test their role in chemotaxis. For example, CCR5 knockout reduces dendritic cell chemotaxis in arthritis models, and TRPM2 knockout impairs maturation and chemotaxis. Knockout models are essential for target validation.
Point Mutation
Introducing point mutations in chemokine receptors or signaling molecules can dissect specific domains required for chemotaxis. For instance, mutating the ligand-binding pocket of CCR7 could reveal residues critical for CCL19-induced migration. Point mutation models help distinguish between receptor activation and downstream signaling.
Knock-in
Knock-in of tagged or fluorescently labeled proteins, such as GFP-tagged CCR7, allows real-time tracking of receptor localization during chemotaxis. This approach can be combined with live-cell microscopy to visualize receptor dynamics in migrating dendritic cells.
Overexpression
Overexpression of chemokines such as CCL5 in dendritic cells can enhance T cell recruitment, as shown in IL-32γ studies. CRISPR activation (CRISPRa) or lentiviral overexpression can be used to study gain-of-function effects on chemotaxis and immune cell interactions.
How EDITGENE Supports dendritic cell chemotaxis Research
Researchers studying dendritic cell chemotaxis-related genes often need to determine whether a candidate gene is causally involved in migration, maturation, or immune cell recruitment. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for dendritic cell chemotaxis research.
Frequently Asked Questions About dendritic cell chemotaxis
What is GO:0002407 dendritic cell chemotaxis?
GO:0002407 is a Gene Ontology biological process term defined as the movement of a dendritic cell in response to an external stimulus.
What genes are involved in dendritic cell chemotaxis?
Key genes include CCR5, CCR7, TRPM2, CCL19, CCL21, and CCL5, which regulate chemokine sensing, calcium signaling, and directed migration.
How is dendritic cell chemotaxis studied?
It is studied using live-cell microscopy, micro-fabricated chemotaxis devices, Transwell assays, and CRISPR knockout models.
What is the role of CCR5 in dendritic cell chemotaxis?
CCR5 mediates dendritic cell chemotaxis in response to chemokines, and its inhibition suppresses arthritis in preclinical models.
How does TRPM2 regulate dendritic cell chemotaxis?
TRPM2 mediates lysosomal calcium release, which is required for dendritic cell maturation and chemotaxis.
Why is dendritic cell chemotaxis important for immunity?
It enables dendritic cells to migrate to lymph nodes and present antigens to T cells, initiating adaptive immune responses.
Can dendritic cell chemotaxis be targeted for autoimmune diseases?
Yes, inhibiting CCR5-mediated chemotaxis with compounds like CT3-1 reduces arthritis severity in mice.
What chemokines attract dendritic cells?
CCL19 and CCL21 attract dendritic cells via CCR7, while CCL5 can recruit T cells to dendritic cells.
How does HIV affect dendritic cell chemotaxis?
Complement-opsonized HIV-1 impairs NK cell chemotaxis toward dendritic cells, contributing to immune evasion.
What CRISPR models are available for dendritic cell chemotaxis research?
EDITGENE offers knockout, point mutation, knock-in, overexpression, and library screening services for genes involved in dendritic cell chemotaxis.
Conclusion
GO:0002407 dendritic cell chemotaxis is a fundamental biological process that governs dendritic cell migration and immune surveillance. Its dysregulation is linked to autoimmune diseases, infections, and cancer. Continued research using advanced CRISPR models and imaging techniques will uncover new therapeutic targets and deepen our understanding of immune cell trafficking.
References
- 1. He J et al.. 2024. Novel artesunate and isatin hybrid CT3-1 suppresses collagen-induced arthritis through abrogating dendritic cell chemotaxis-induced by CCR5.. Int Immunopharmacol 136:112264 PMID: 38810308
- 2. Vargas P et al.. 2016. Study of dendritic cell migration using micro-fabrication.. J Immunol Methods 432:30-4 PMID: 26684937
- 3. Sumoza-Toledo A et al.. 2011. Dendritic cell maturation and chemotaxis is regulated by TRPM2-mediated lysosomal Ca2+ release.. FASEB J 25(10):3529-42 PMID: 21753080
- 4. Randolph GJ et al.. 2005. Dendritic-cell trafficking to lymph nodes through lymphatic vessels.. Nat Rev Immunol 5(8):617-28 PMID: 16056255
- 5. Loef EJ et al.. 2021. Live-Cell Microscopy Reveals That Human T Cells Primarily Respond Chemokinetically Within a CCL19 Gradient That Induces Chemotaxis in Dendritic Cells.. Front Immunol 12:628090 PMID: 33841411
- 6. Ellegård R et al.. 2015. Impaired NK Cell Activation and Chemotaxis toward Dendritic Cells Exposed to Complement-Opsonized HIV-1.. J Immunol 195(4):1698-704 PMID: 26157174
- 7. Son MH et al.. 2014. IL-32γ induces chemotaxis of activated T cells via dendritic cell-derived CCL5.. Biochem Biophys Res Commun 450(1):30-5 PMID: 24882804
- 8. Burton GF et al.. 1995. Follicular dendritic cells and B cell chemotaxis.. Eur J Immunol 25(4):1105-8 PMID: 7737280
